|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/2827 | (2013.01) |
| C07K 14/71 | (2006.01) | ||
| C07K 16/22 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K 16/46 | (2006.01) | ||
| A61K 38/177 | (2013.01) | ||
| C07K 19/00 | (2006.01) | ||
| C07K 14/71 | (2013.01) | ||
| C07K2319/33 | (2013.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 11/04 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61P 5/14 | (2018.01) | ||
| A61P 7/00 | (2018.01) |
| (11) | Number of the document | 3889172 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21165709.3 |
| Date of filing the European patent application | 2015-02-10 | |
| (97) | Date of publication of the European application | 2021-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201461938048 P | 2014-02-10 | US |
| (72) |
LO, Kin-Ming , US
|
| (73) |
Merck Patent GmbH ,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (54) | TARGETED TGF BETA INHIBITION |
| TARGETED TGF BETA INHIBITION |